[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100544549":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":37,"centralContacts":41,"locations":50,"responsibleParty":62,"collaborators":27,"id":64,"slug":27,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":27,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":27,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":27,"overallStatus":52,"whyStopped":27,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"NYU Langone Health","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group","EXPERIMENTAL","Participants randomized to the intervention group will undergo neuromuscular electrical stimulation (NMES) five days a week beginning three weeks postoperative and lasting for ten weeks. The intervention group will begin standard physical therapy at six weeks postoperative.",[13,14,15],"Procedure: VPOD Wireless Tens Unit","Procedure: Physical Therapy","Device: Biodex",{"label":17,"type":18,"description":19,"interventionNames":20},"Control Group","ACTIVE_COMPARATOR","Participants randomized to the control group will begin standard physical therapy at six weeks postoperative.",[14,15],[22,28,32],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"PROCEDURE","VPOD Wireless Tens Unit","The VPOD unit will deliver NMES to participants in the Intervention Group.",[9],null,{"type":23,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"Physical Therapy","Physical therapy as per standard of care.",[17,9],{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":27},"DEVICE","Biodex","Used to assess strength, endurance, power, and range of motion.",[17,9],[38],{"name":39,"affiliation":5,"role":40},"Raymond J. Walls, MD","PRINCIPAL_INVESTIGATOR",[42,46],{"name":39,"role":43,"phone":44,"phoneExt":27,"email":45},"CONTACT","(917) 780-8720","Raymond.Walls@nyulangone.org",{"name":47,"role":43,"phone":48,"phoneExt":27,"email":49},"Thelma Jimenez Mosquea, MD","(347) 880-2254","Thelma.JimenezMosquea@nyulangone.org",[51],{"facility":5,"status":52,"city":53,"state":53,"zip":54,"country":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":27},"RECRUITING","New York","10016","United States",{"type":57,"coordinates":58},"Point",[59,60],-74.00597,40.71427,{"lat":60,"lon":59},{"type":63,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100544549",false,"NCT06370325","Neuromuscular Electrical Stimulation in Foot and Ankle Surgery","Neuromuscular Electrical Stimulation in Foot and Ankle Surgery: A Pilot Study","Inclusion Criteria:\n\n* Capable and willing to provide informed consent\n* Undergoing a procedure that involves repairing an ankle fracture.\n\nExclusion Criteria:\n\nPatients with medical histories that include:\n\n* Rheumatoid arthritis\n* Connective tissue disorders\n* Chronic corticosteroid use\n* Implanted electrical devices\n* Neurological disorders\n* Non-ambulatory status\n* Recent surgery (within the last 3 months) that is not related to the study\n* Scheduled to undergo surgery in the near future\n* Epilepsy\n* Diagnosed with cancer\n* Have suffered acute trauma or recently have had a surgical procedure (not related to the study)\n* Have cardiac problems or cardiac disease\n* Have an abdominal hernia\n* Have venous thrombosis","ALL","18 Years","70 Years",{"count":74,"type":75},20,"ESTIMATED","INTERVENTIONAL",[78],"NA","This is a pilot randomized controlled trial, wherein the intervention group will undergo NMES five days a week beginning three weeks postoperative and lasting for ten weeks. Both the control and intervention groups will start standard physical therapy six weeks postoperative. Primary outcome measure will be the isometric strength of the gastrocnemius muscle. The secondary outcomes will comprise subjective clinical evaluations (using the Lower Extremity Functional Scale \\[LEFS\\]), functional assessments such as the sit-to-stand test, 2-minute walk test, stair climb test and objective clinical evaluation using contralateral comparison of calf circumference.",[81],"Ankle Fractures","2026-02-25",{"date":84,"type":85},"2026-02-27","ACTUAL",{"date":87,"type":85},"2025-06-19",{"date":89,"type":75},"2026-12-30",{"name":5,"class":6},1]